The occurrence of Simpson's paradox if site-level effect was ignored in the TREAT Asia HIV Observational Database

被引:3
|
作者
Jiamsakul, Awachana [1 ]
Kerr, Stephen J. [2 ,3 ]
Chandrasekaran, Ezhilarasi [4 ]
Huelgas, Aizobelle [5 ]
Taecharoenkul, Sineenart [6 ]
Teeraananchai, Sirinya [2 ]
Wan, Gang [7 ]
Ly, Penh Sun [8 ]
Kiertiburanakul, Sasisopin [9 ]
Law, Matthew [1 ]
机构
[1] UNSW Australia, Kirby Inst, Sydney, NSW 2052, Australia
[2] Thai Red Cross AIDS Res Ctr, HIV NAT, Bangkok, Thailand
[3] Univ Amsterdam, Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, Acad Med Ctr, Amsterdam, Netherlands
[4] YRGCARE Med Ctr, Chennai, Tamil Nadu, India
[5] Res Inst Trop Med, Manila, Philippines
[6] Res Inst Hlth Sci, Chiang Mai, Thailand
[7] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China
[8] Natl Ctr HIV AIDS Dermatol & STDs, Phnom Penh, Cambodia
[9] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok, Thailand
基金
美国国家卫生研究院;
关键词
Simpson's paradox; Clustering; Human immunodeficiency virus; Cohort; Yule-Simpson; Cox; ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; IMMUNOLOGICAL RESPONSE; DRUG-RESISTANCE; MORTALITY; COHORT; ADULTS; PERFORMANCE; CHILDREN; PROGRAMS;
D O I
10.1016/j.jclinepi.2016.01.030
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: In multisite human immunodeficiency virus (HIV) observational cohorts, clustering of observations often occurs within sites. Ignoring clustering may lead to "Simpson's paradox" (SP) where the trend observed in the aggregated data is reversed when the groups are separated. This study aimed to investigate the SP in an Asian HIV cohort and the effects of site-level adjustment through various Cox regression models. Study Design and Setting: Survival time from combination antiretroviral therapy (cART) initiation was analyzed using four Cox models: (1) no site adjustment; (2) site as a fixed effect; (3) stratification through site; and (4) shared frailty on site. Results: A total of 6,454 patients were included from 23 sites in Asia. SP was evident in the year of cART initiation variable. Model (1) shows the hazard ratio (HR) for years 2010-2014 was higher than the HR for 2006-2009, compared to 2003-2005 (HR = 0.68 vs. 0.61). Models (2) (4) consistently implied greater improvement in survival for those who initiated in 2010-2014 than 2006-2009 contrasting findings from model (1). The effects of other significant covariates on survival were similar across four models. Conclusions: Ignoring site can lead to SP causing reversal of treatment effects. Greater emphasis should be made to include site in urvival models when possible. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:183 / 192
页数:10
相关论文
共 46 条
  • [41] Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database
    Zhou, Jialun
    Sirisanthana, Thira
    Kiertiburanakul, Sasisopin
    Chen, Yi-Ming A.
    Han, Ning
    Lim, Poh Lian
    Kumarasamy, Nagalingeswaran
    Choi, Jun Yong
    Merati, Tuti Parwati
    Yunihastuti, Evy
    Oka, Shinichi
    Kamarulzaman, Adeeba
    Phanuphak, Praphan
    Lee, Christopher K. C.
    Li, Patrick C. K.
    Pujari, Sanjay
    Saphonn, Vanthanak
    Law, Matthew G.
    BMC INFECTIOUS DISEASES, 2010, 10
  • [42] Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database
    Jialun Zhou
    Thira Sirisanthana
    Sasisopin Kiertiburanakul
    Yi-Ming A Chen
    Ning Han
    Poh_Lian Lim
    Nagalingeswaran Kumarasamy
    Jun Yong Choi
    Tuti Parwati Merati
    Evy Yunihastuti
    Shinichi Oka
    Adeeba Kamarulzaman
    Praphan Phanuphak
    Christopher KC Lee
    Patrick CK Li
    Sanjay Pujari
    Vanthanak Saphonn
    Matthew G Law
    BMC Infectious Diseases, 10
  • [43] HIV viral suppression in TREAT Asia HIV Observational Database enrolled adults on antiretroviral therapy at the Social Health Clinic, the National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia
    Boettiger, David C.
    Khol, Vohith
    Durier, Nicolas
    Law, Matthew
    Sun, Ly Penh
    ANTIVIRAL THERAPY, 2016, 21 (08) : 725 - 730
  • [44] Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database
    Han, S. H.
    Zhou, J.
    Lee, M. P.
    Zhao, H.
    Chen, Y-M A.
    Kumarasamy, N.
    Pujari, S.
    Lee, C.
    Omar, S. F. S.
    Ditangco, R.
    Phanuphak, N.
    Kiertiburanakul, S.
    Chaiwarith, R.
    Merati, T. P.
    Yunihastuti, E.
    Tanuma, J.
    Saphonn, V.
    Sohn, A. H.
    Choi, J. Y.
    HIV MEDICINE, 2014, 15 (02) : 77 - 85
  • [45] Trends in CD4 cell count response to first-line antiretroviral treatment in HIV-positive patients from Asia, 2003-2013: TREAT Asia HIV Observational Database Low Intensity Transfer
    De La Mata, Nicole L.
    Ly, Penh S.
    Ng, Oon T.
    Nguyen, Kinh V.
    Merati, Tuti P.
    Pham, Thuy T.
    Lee, Man P.
    Choi, Jun Y.
    Sohn, Annette H.
    Law, Matthew G.
    Kumarasamy, Nagalingeswaran
    INTERNATIONAL JOURNAL OF STD & AIDS, 2017, 28 (13) : 1282 - 1291
  • [46] AIDS-defining illness diagnosed within 90 days after starting highly active antiretroviral therapy among patients from the TREAT Asia HIV Observational Database
    Zhou, J.
    Paton, N. I.
    Ditangco, R.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2007, 18 (07) : 446 - 452